Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant NKG2A (Monalizumab Biosimilar) anticorps

Cet anticorps anti-NKG2A (Monalizumab Biosimilar) est un anticorps Human Monoclonal détectant NKG2A (Monalizumab Biosimilar) dans FACS, ELISA, BLI, Func et SPR. Adapté pour Humain.
N° du produit ABIN7581587

Aperçu rapide pour Recombinant NKG2A (Monalizumab Biosimilar) anticorps (ABIN7581587)

Antigène

NKG2A (Monalizumab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 4
  • 1
Human

Clonalité

  • 4
  • 1
Monoclonal

Conjugué

  • 4
  • 1
Cet anticorp NKG2A (Monalizumab Biosimilar) est non-conjugé

Application

Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Fonction

    Anti-NKG2A / CD94 Reference Antibody (monalizumab)

    Séquence

    QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYWMNWVRQA PGQGLEWMGR IDPYDSETHY AQKLQGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARGG YDFDVGTLYW FFDVWGQGTT VTVSSASTKG PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL SSVVTVPSSS LGTKTYTCNV DHKPSNTKVD KRVESKYGPP CPPCPAPEFL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSQEDPEVQF NWYVDGVEVH NAKTKPREEQ FNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KGLPSSIEKT ISKAKGQPRE PQVYTLPPSQ EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSRLTVDKS RWQEGNVFSC SVMHEALHNH YTQKSLSLSL GK,DIQMTQSPSS LSASVGDRVT ITCRASENIY SYLAWYQQKP GKAPKLLIYN AKTLAEGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQH HYGTPRTFGG GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    Attributs du produit

    Anti-NKG2A / CD159a Reference Antibody (monalizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Pureté

    >95 %

    Isotype

    IgG4 S228P
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    Therapeutic Agents by Target and Mechanism: NKG2A antagonist

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Stock

    4 °C,-80 °C

    Stockage commentaire

    +4°C,-80°C
  • Antigène

    NKG2A (Monalizumab Biosimilar)

    Classe de substances

    Biosimilar

    Poids moléculaire

    145.5 kDa

    UniProt

    P26715
Vous êtes ici:
Chat with us!